Type / Class
Equity / Common stock, par value $0.001 per share
Shares outstanding
148,275,293
Number of holders
157
Total 13F shares, excl. options
77,249,037
Shares change
+6,257,089
Total reported value, excl. options
$1,463,933,277
Value change
+$131,611,867
Put/Call ratio
237%
Number of buys
105
Number of sells
-69
Price
$18.95

Significant Holders of 89bio, Inc. - Common stock, par value $0.001 per share (ETNB) as of Q2 2023

222 filings reported holding ETNB - 89bio, Inc. - Common stock, par value $0.001 per share as of Q2 2023.
89bio, Inc. - Common stock, par value $0.001 per share (ETNB) has 157 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 77,249,037 shares of 148,275,293 outstanding shares and own 52% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (11,416,948 shares), BlackRock Inc. (4,650,183 shares), STATE STREET CORP (4,643,191 shares), JANUS HENDERSON GROUP PLC (4,119,918 shares), PICTET ASSET MANAGEMENT SA (3,575,126 shares), VANGUARD GROUP INC (3,369,941 shares), Holocene Advisors, LP (2,638,499 shares), SUVRETTA CAPITAL MANAGEMENT, LLC (2,393,236 shares), FEDERATED HERMES, INC. (2,133,905 shares), and Boxer Capital, LLC (2,100,000 shares).
This table shows the top 157 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.